Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Incidence of Fatty Liver Disease rises as obesity in children increases

Incidence of Fatty Liver Disease rises as obesity in children increases

March 16, 2007

INDIANAPOLIS — Indiana University School of Medicine researchers are taking a closer look at a disease whose incidence is rising as obesity in children increases. Non-Alcoholic Steatohepatitis, more popularly known as Fatty Liver Disease, occurs in approximately 15% of obese children. Fatty Liver Disease, in which fat accumulates in the liver, while not life threatening in children, can lead to cirrhosis (scarring) of the liver, sometimes requiring transplantation by adulthood.

"Until now the only treatment for Fatty Liver Disease has been to offer diet and exercise counseling, but this is often not effective. As part of a national multicenter research network, we are now looking at Vitamin E and at metformin, a drug used to treat Type II diabetes, as possible therapies" said Jean Molleston, M.D., clinical professor of pediatrics at IU School of Medicine and director of pediatric gastroenterology at Riley Hospital for Children. Dr. Molleston is the pediatric principal investigator for the IU School of Medicine site of TONIC, an eight-center Phase III study funded by the National Institute of Diabetes and Digestive and Kidney Disease, which is investigating treatment options for Fatty Liver Disease in 8 to 17 year olds and is the largest study of its type to date.




"We are seeing a growing number of young people with Fatty Liver Disease, and we need to tackle the disease before it becomes full blown in adulthood," said Dr. Molleston. "We routinely test children for conditions with much lower incidence such as scoliosis. Although we do not yet have formal guidelines for screening for Fatty Liver Disease, I personally think that all obese children should be screened for Fatty Liver Disease so we can intervene before it damages the liver."

A simple blood test to determine if liver enzyme levels are elevated alerts pediatricians that the child needs to be evaluated for Fatty Liver Disease.

Approximately a third of children and teens in the United States are overweight and 15% of children and teens are obese. Fatty Liver Disease may exist in 15% or more of obese children.

The American Liver Foundation estimates that 10-20% of Americans have Fatty Liver Disease.

Indiana University



Related Fatty Liver Disease Current Events and Fatty Liver Disease News Articles Fatty Liver Disease Current Events and Fatty Liver Disease News RSS Fatty Liver Disease Current Events and Fatty Liver Disease News RSS
Metabolic syndrome linked to liver disease in obese teenaged boys
Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.

Second-hand smoking results in liver disease, study finds
A team of scientists at the University of California, Riverside has found that even second-hand tobacco smoke exposure can result in nonalcoholic fatty liver disease (NAFLD), a common disease and rising cause of chronic liver injury in which fat accumulates in the liver of people who drink little or no alcohol.

Food additive may one day help control blood lipids and reduce disease risk
Scientists at Washington University School of Medicine in St. Louis have identified a substance in the liver that helps process fat and glucose. That substance is a component of the common food additive lecithin, and researchers speculate it may one day be possible to use lecithin products to control blood lipids and reduce risk for diabetes, hypertension or cardiovascular disease using treatments delivered in food rather than medication.

Genetically engineered mice yield clues to 'knocking out' cancer
Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development of cancer.

Hyperferritinemia is another surrogate marker of advanced liver disease
High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients.

Calorie restriction causes temporal changes in liver metabolism
Moderate calorie restriction causes temporal changes in the liver and skeletal muscle metabolism, whereas moderate weight loss affects muscle.

Difference in fat storage may explain lower rate of liver disease in African-Americans
Where different ethnic groups store fat in their bodies may account for differences in the likelihood they'll develop insulin resistance and non-alcoholic fatty liver disease, researchers at UT Southwestern Medical Center have found.

Is telmisartan effective in treating non-alcoholic steatohepatitis?
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma.

Potential atherosclerosis drug exhibits no harmful side-effects in liver
Researchers have developed and tested a synthetic atherosclerosis drug that can reduce the build-up of dangerous blood vessel plaques without producing the side-effect of fatty liver disease (which leads to its own set of problems like diabetes). The encouraging results of this study in mice could lead to a new type of drug to treat or even prevent atherosclerosis.

New obesity staging system may help doctors measure up
A new system proposed by Canadian and US obesity researchers may provide another weapon in the battle against obesity. University of Alberta obesity expert Dr. Arya Sharma, along with a researcher from Northwestern University in Chicago, Illinois, has proposed a classification system to help doctors assess and treat overweight patients.
More Fatty Liver Disease Current Events and Fatty Liver Disease News Articles
Fatty Liver Disease: NASH and Related Disorders

Fatty Liver Disease: NASH and Related Disorders
by Geoffrey C. Farrell (Editor), Jacob George (Editor), Pauline la M. de Hall (Editor), Arthur J. McCullough (Editor)

Fatty Liver Diseases: NASH and Related Disorders is an unusual book: it combines a practical approach for students and physicians concerned with the problem with a clear overview on the causative mechanisms. It appeals to doctors and other health care workers who encounter this problem, as well as to pathologists and investigators interested in the field of liver disease.


It will improve your diagnostic acumen for people with abnormal liver tests, advance your knowledge about this important subject and help with your specialist or undergraduate exams, and management of a common disorder.

Wasabi Cleanse 200mg 30 Tablets

Wasabi Cleanse 200mg 30 Tablets
by Source Naturals

Wasabi CleanseTM Supports Liver Detoxification The root of the herb Wasabia japonica, a potent member of the Cruciferae family, has powerful properties that can help detoxify the liver. Wasabi induces Phase II detoxification, which removes toxic substances that are stored in the liver's fatty tissues.

  Biopsy can be tricky in fatty liver disease.(Digestive Disorders): An article from: Family Practice News
by Robert Finn (Author)

This digital document is an article from Family Practice News, published by Thomson Gale on March 15, 2006. The length of the article is 668 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Biopsy can be tricky in fatty liver disease.(Digestive Disorders)
Author: Robert Finn
Publication: Family Practice News (Magazine/Journal)
Date: March 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 6 Page: 63(1)

Distributed by Thomson...

  Lifestyle changes improve NASH.(News)(nonalcoholic fatty liver disease ): An article from: Pediatric News
by Mary Ann Moon (Author)

This digital document is an article from Pediatric News, published by Thomson Gale on October 1, 2006. The length of the article is 528 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Lifestyle changes improve NASH.(News)(nonalcoholic fatty liver disease )
Author: Mary Ann Moon
Publication: Pediatric News (Magazine/Journal)
Date: October 1, 2006
Publisher: Thomson Gale
Volume: 40 Issue: 10 Page: 2(1)

Distributed by Thomson...

  Fatty liver disease common in U.S. adolescents.(Digestive Disorders): An article from: Family Practice News
by Mitchel L. Zoler (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 15, 2005. The length of the article is 859 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Fatty liver disease common in U.S. adolescents.(Digestive Disorders)
Author: Mitchel L. Zoler
Publication: Family Practice News (Magazine/Journal)
Date: February 15, 2005
Publisher: International Medical News Group
Volume: 35 Issue: 4 Page: 66(1)

Distributed by Thomson...

  Nonalcoholic fatty liver disease lacks effective therapies.(Gastroenterology): An article from: Internal Medicine News
by Jeff Evans (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on November 15, 2004. The length of the article is 908 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Nonalcoholic fatty liver disease lacks effective therapies.(Gastroenterology)
Author: Jeff Evans
Publication: Internal Medicine News (Magazine/Journal)
Date: November 15, 2004
Publisher: International Medical News Group
Volume: 37 Issue: 22 Page: 57(1)

Distributed by Thomson...

  Rising prevalence of obesity is boosting risk of fatty liver disease and NASH.(Gastroenterology): An article from: Internal Medicine News
by Miriam E. Tucker (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on June 15, 2004. The length of the article is 602 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rising prevalence of obesity is boosting risk of fatty liver disease and NASH.(Gastroenterology)
Author: Miriam E. Tucker
Publication: Internal Medicine News (Magazine/Journal)
Date: June 15, 2004
Publisher: International Medical News Group
Volume: 37 Issue: 12 Page: 62(1)

Distributed by Thomson...

Livatone Plus Powder 200gm

Livatone Plus Powder 200gm
by SCB Intl Inc

Livatone Plus Powder contains natural ingredients designed by Dr. Sandra Cabot to support the detoxification pathways in the liver and to assist healthy liver function. Livatone Plus Powder helps to rid the body of waste and promotes elimination. Drink at least 6 to 8 glasses of pure water daily and increase fiber in diet.

  Two factors refine diagnosis in fatty liver disease. (Biopsy Still Necessary).(type 2 diabetes and elevated levels of alanine aminotransferase)(Brief Article): An article from: Family Practice News
by Nicholas Mulcahy (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2003. The length of the article is 367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Two factors refine diagnosis in fatty liver disease. (Biopsy Still Necessary).(type 2 diabetes and elevated levels of alanine aminotransferase)(Brief Article)
Author: Nicholas Mulcahy
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 3 Page: 24(1)

Article Type:...

  Rule out eight conditions before fatty liver disease Dx.(Gastroenterology)(Clinical report): An article from: Internal Medicine News
by Sherry Boschert (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on October 1, 2006. The length of the article is 728 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rule out eight conditions before fatty liver disease Dx.(Gastroenterology)(Clinical report)
Author: Sherry Boschert
Publication: Internal Medicine News (Magazine/Journal)
Date: October 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 19 Page: 50(1)

Article Type: Clinical report

Distributed by Thomson...

© 2009 BrightSurf.com